Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.verified

HOTH

Price:

$0.779

Market Cap:

$5.38M

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung dis...[Read more]

Industry

Biotechnology

IPO Date

2019-02-15

Stock Exchange

NASDAQ

Ticker

HOTH

The Enterprise Value as of December 2024 (TTM) for Hoth Therapeutics, Inc. (HOTH) is -2610896.00

According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -2610896.00. This represents a change of 10.20% compared to the average of -2369146.14 of the last 4 quarters.

Hoth Therapeutics, Inc. (HOTH) Historical Enterprise Value (quarterly & annually)

How has HOTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Hoth Therapeutics, Inc. over the last ten years is 35.34M. The current -2610896.00 Enterprise Value has changed -838.85% with respect to the historical average. Over the past ten years (40 quarters), HOTH's Enterprise Value was at its highest in in the March 2018 quarter at 81.62M. The Enterprise Value was at its lowest in in the March 2023 quarter at -7929764.56.

Quarterly (TTM)
Annual

Average

35.34M

Median

26.67M

Minimum

-4327953.40

Maximum

80.76M

Hoth Therapeutics, Inc. (HOTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hoth Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 80.76M

Minimum Annual Increase = -248.62%

Minimum Annual Enterprise Value = -4327953.40

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-4327953.40-248.62%
20222.91M-53.03%
20216.20M-76.75%
202026.67M-51.54%
201955.04M-31.30%
201880.11M-0.81%

Hoth Therapeutics, Inc. (HOTH) Average Enterprise Value

How has HOTH Enterprise Value performed in the past?

The current Enterprise Value of Hoth Therapeutics, Inc. (HOTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.59M

5-year avg

17.30M

10-year avg

35.34M

Hoth Therapeutics, Inc. (HOTH) Enterprise Value vs. Peers

How is HOTH’s Enterprise Value compared to its peers?

Hoth Therapeutics, Inc.’s Enterprise Value is less than Avenue Therapeutics, Inc. (1.03M), greater than Revelation Biosciences, Inc. (-3905412.00), less than NeuroBo Pharmaceuticals, Inc. (-1181216.00), less than Virax Biolabs Group Limited (3.97M), greater than Zura Bio Limited (-33475334.00), greater than Phio Pharmaceuticals Corp. (-2941890.00), less than Sonnet BioTherapeutics Holdings, Inc. (4.41M), less than 180 Life Sciences Corp. (4.88M), less than Cardio Diagnostics Holdings, Inc. (39.38M), less than Baudax Bio, Inc. (0), greater than TRACON Pharmaceuticals, Inc. (-6160275.00), less than Aditxt, Inc. (12.51M), less than Quoin Pharmaceuticals, Ltd. (-667131.00), greater than Allarity Therapeutics, Inc. (-12603741.00), less than Kiromic BioPharma, Inc. (13.21M), less than Biodexa Pharmaceuticals Plc (747.25M), less than Blue Water Vaccines, Inc. (12.49M), less than Hillstream BioPharma, Inc. (1.48M), less than Kiora Pharmaceuticals, Inc. (4.28M),

Build a custom stock screener for Hoth Therapeutics, Inc. (HOTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hoth Therapeutics, Inc. (HOTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hoth Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Hoth Therapeutics, Inc. (HOTH)?

What is the 3-year average Enterprise Value for Hoth Therapeutics, Inc. (HOTH)?

What is the 5-year average Enterprise Value for Hoth Therapeutics, Inc. (HOTH)?

How does the current Enterprise Value for Hoth Therapeutics, Inc. (HOTH) compare to its historical average?